Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-096161
Filing Date
2011-11-08
Accepted
2011-11-08 06:07:29
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c23891e10vq.htm 10-Q 305961
2 EXHIBIT 10.2 c23891exv10w2.htm EX-10.2 26654
3 EXHIBIT 31.1 c23891exv31w1.htm EX-31.1 8645
4 EXHIBIT 31.2 c23891exv31w2.htm EX-31.2 8660
5 EXHIBIT 32.1 c23891exv32w1.htm EX-32.1 4498
  Complete submission text file 0000950123-11-096161.txt   1703459

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT anx-20110930.xml EX-101.INS 181658
7 EX-101 SCHEMA DOCUMENT anx-20110930.xsd EX-101.SCH 15210
8 EX-101 CALCULATION LINKBASE DOCUMENT anx-20110930_cal.xml EX-101.CAL 44776
9 EX-101 LABELS LINKBASE DOCUMENT anx-20110930_lab.xml EX-101.LAB 135890
10 EX-101 PRESENTATION LINKBASE DOCUMENT anx-20110930_pre.xml EX-101.PRE 81292
Mailing Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130 8585520866
ADVENTRX PHARMACEUTICALS INC (Filer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 111186142
SIC: 2834 Pharmaceutical Preparations